TXMD insider filings

TherapeuticsMD, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-12-29. Screen TXMD transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TXMD between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — TherapeuticsMD, Inc.

FiledFormInsiderReported transactionsSource
2025-12-294Thompson Tommy G — DirectorPurchase (P): 8,400 @ $1.67EDGAR
2025-11-054Walker Marlan D — Chief Executive OfficerGrant/award (A): 67,492 (derivative) @ $0EDGAR
2025-11-054Collins Cooper C. — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2025-11-054Thompson Tommy G — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2025-11-054Naughton Gail K — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2025-04-154Walker Marlan D — Chief Executive OfficerPurchase (P): 490 @ $1.00EDGAR
2025-04-154Thompson Tommy G — DirectorPurchase (P): 325 @ $1.00EDGAR
2025-04-104Walker Marlan D — Chief Executive OfficerPurchase (P): 1,136 @ $0.87 · Purchase (P): 1,167 @ $0.86EDGAR
2025-02-204Walker Marlan D — Chief Executive OfficerOption exercise (M): 3,467 @ $0 · Option exercise (M): 2,311 @ $0 · Option exercise (M): 770 @ $0 · Option exercise (M): 1,733 @ $0 · Option exercise (M): 3,467 (derivative) @ $0 · Option exercise (M): 2,311 (derivative) @ $0 · +2 moreEDGAR
2025-02-204Collins Cooper C. — DirectorOption exercise (M): 8,500 @ $0 · Option exercise (M): 8,500 (derivative) @ $0EDGAR
2025-02-204Thompson Tommy G — DirectorOption exercise (M): 8,500 @ $0 · Option exercise (M): 8,500 (derivative) @ $0EDGAR
2025-02-204Naughton Gail K — DirectorOption exercise (M): 8,500 @ $0 · Option exercise (M): 8,500 (derivative) @ $0EDGAR
2024-08-264Collins Cooper C. — DirectorPurchase (P): 4,094 @ $1.73EDGAR
2024-08-234Collins Cooper C. — DirectorPurchase (P): 1,200 @ $1.70EDGAR
2023-12-074Walker Marlan D — Chief Executive OfficerOption exercise (M): 70,000 @ $0 · Sale (S): 14,500 @ $2.31 · Sale (S): 4,550 @ $2.24 · Option exercise (M): 70,000 (derivative) @ $0EDGAR
2023-11-174Rubric Capital Management LP — Director, 10% owner
Rosen David Efraim — 10% owner
Grant/award (A): 877,192 @ $2.28EDGAR
2023-08-214ZIEGLER JOSEPH — Principal Financial OfficerGrant/award (A): 7,500 @ $0EDGAR
2023-07-194Collins Cooper C. — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2023-07-194Thompson Tommy G — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2023-07-194Naughton Gail K — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2023-06-294Rubric Capital Management LP — Director, 10% owner
Rosen David Efraim — Director, 10% owner
Grant/award (A): 312,525 @ $3.68EDGAR
2023-05-044/AWalker Marlan D — Chief Executive OfficerOption exercise (M): 1,010 @ $0 · Option exercise (M): 1,734 @ $0 · Sale (S): 692 @ $3.64 · Option exercise (M): 1,010 (derivative) @ $0 · Option exercise (M): 1,734 (derivative) @ $0EDGAR
2023-04-144Walker Marlan D — Chief Executive OfficerOption exercise (M): 3,030 @ $0 · Option exercise (M): 1,010 @ $0 · Option exercise (M): 1,734 @ $0 · Option exercise (M): 1,734 @ $0 · Sale (S): 1,170 @ $3.65 · Option exercise (M): 3,030 (derivative) @ $0 · +3 moreEDGAR
2023-04-144Donegan Michael C — Prin. Fin. and Acctg. OfficerOption exercise (M): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2023-02-234Walker Marlan D — Chief Executive OfficerGrant/award (A): 70,000 (derivative) @ $0EDGAR
2023-02-234Donegan Michael C — Prin. Fin. and Acctg. OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2023-02-224/ARubric Capital Management LP — Director, 10% owner
Rosen David Efraim — Director, 10% owner
Disposition to issuer (D): 29,000 @ $1,333EDGAR
2023-01-304Donegan Michael C — Prin. Fin. and Acctg. OfficerOption exercise (M): 2,400 @ $0 · Option exercise (M): 2,400 @ $0 · Option exercise (M): 1,140 @ $0 · Sale (S): 1,648 @ $5.08 · Sale (S): 49 @ $5.09 · Option exercise (M): 2,400 (derivative) @ $0 · +2 moreEDGAR
2023-01-254Donegan Michael C — Prin. Fin. and Acctg. OfficerOption exercise (M): 380 @ $0 · Option exercise (M): 1,066 @ $0 · Option exercise (M): 519 @ $0 · Option exercise (M): 2,400 @ $0 · Sale (S): 1,302 @ $5.34 · Sale (S): 7 @ $5.31 · +4 moreEDGAR
2023-01-034Rubric Capital Management LP — 10% owner
Rosen David Efraim — 10% owner
Sale (S): 29,000 @ $1,333EDGAR
2022-12-124Rubric Capital Management LP — 10% owner
Rosen David Efraim — 10% owner
Purchase (P): 14,825 @ $6.09EDGAR
2022-12-094Walker Marlan D — General CounselOption exercise (M): 1,010 @ $0 · Option exercise (M): 1,156 @ $0 · Option exercise (M): 388 @ $0 · Sale (S): 1,048 @ $4.95 · Option exercise (M): 1,010 (derivative) @ $0 · Option exercise (M): 1,156 (derivative) @ $0 · +1 moreEDGAR
2022-12-094Rubric Capital Management LP — 10% owner
Rosen David Efraim — 10% owner
Purchase (P): 20,113 @ $5.66 · Purchase (P): 300 @ $5.83EDGAR
2022-12-094Donegan Michael C — Interim CFO/CAO/VP of FinanceOption exercise (M): 2,300 @ $0 · Option exercise (M): 380 @ $0 · Option exercise (M): 534 @ $0 · Option exercise (M): 262 @ $0 · Sale (S): 910 @ $4.78 · Option exercise (M): 2,300 (derivative) @ $0 · +3 moreEDGAR
2022-12-094Bernick Brian — Co-Chief Executive OfficerOption exercise (M): 3,167 @ $0 · Sale (S): 935 @ $4.92 · Sale (S): 320 @ $6.31 · Option exercise (M): 3,167 (derivative) @ $0EDGAR
2022-12-094Glickman Mark A — Co-Chief Executive OfficerOption exercise (M): 1,734 @ $0 · Sale (S): 440 @ $4.92 · Option exercise (M): 1,734 (derivative) @ $0EDGAR
2022-12-084Naughton Gail K — DirectorSale (S): 3,922 @ $5.26EDGAR
2022-10-314Rubric Capital Management LP — 10% owner
Rosen David Efraim — 10% owner
Purchase (P): 7,000 @ $1,000EDGAR
2022-10-034Rubric Capital Management LP — 10% owner
Rosen David Efraim — 10% owner
Purchase (P): 7,000 @ $1,000EDGAR
2022-10-034Ling Karen — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2022-10-034Russell Angus C. — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2022-10-034MUSING JULES A. — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2022-10-034Collins Cooper C. — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2022-10-034Thompson Tommy G — DirectorGrant/award (A): 34,175 (derivative) @ $0EDGAR
2022-10-034Naughton Gail K — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2022-10-034BISARO PAUL — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2022-08-224Collins Cooper C. — DirectorOption exercise (M): 1,984 · Option exercise (M): 1,984 (derivative) @ $0EDGAR
2022-08-224Thompson Tommy G — DirectorOption exercise (M): 2,976 · Option exercise (M): 2,976 (derivative) @ $0EDGAR
2022-08-224Naughton Gail K — DirectorOption exercise (M): 1,984 · Option exercise (M): 1,984 (derivative) @ $0EDGAR
2022-08-224BISARO PAUL — DirectorOption exercise (M): 1,984 · Option exercise (M): 1,984 (derivative) @ $0EDGAR

Recent 8-K events — TherapeuticsMD, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-308-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-218-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-11-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-05-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-04-098-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TXMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs